Patents by Inventor Byoung Ki AHN

Byoung Ki AHN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stable pharmaceutical composition comprising testosterone undecanoate
    Patent number: 11826460
    Abstract: The present invention relates to an injectable composition of testosterone ester for the treatment of testosterone deficiency. Particularly, the present invention relates to a pharmaceutical composition comprising testosterone undecanoate, which is capable of increasing the convenience for use in injection with the low viscosity and injection force, and has improved stability.
    Type: Grant
    Filed: June 27, 2019
    Date of Patent: November 28, 2023
    Assignee: Chong Kun Dang Pharmaceutical Corp.
    Inventors: Byoung Ki Ahn, So Hyun Park
  • A Stable Pharmaceutical Composition Comprising Testosterone Undecanoate
    Publication number: 20210259958
    Abstract: The present invention relates to an injectable composition of testosterone ester for the treatment of testosterone deficiency. Particularly, the present invention relates to a pharmaceutical composition comprising testosterone undecanoate, which is capable of increasing the convenience for use in injection with the low viscosity and injection force, and has improved stability.
    Type: Application
    Filed: June 27, 2019
    Publication date: August 26, 2021
    Applicant: Chong Kun Dang Pharmaceutical Corp.
    Inventors: Byoung Ki Ahn, So Hvun Park
  • PHARMACEUTICAL COMPOSITION COMPRISING 5ALPHA-REDUCTASE INHIBITOR
    Publication number: 20180207146
    Abstract: Disclosed is a composition comprising a 5?-reductase inhibitor. Forming a liquid crystal upon exposure to an aqueous fluid, the composition can release the 5?-reductase inhibitor at a constant rate over a long period of time. In addition, the composition can significantly alleviate irritations attributed to the topical administration of the 5?-reductase inhibitor, and thus the composition has improved safety.
    Type: Application
    Filed: July 20, 2015
    Publication date: July 26, 2018
    Inventors: Byoung Ki AHN, Ki Seong KO, So Hyun PARK, Min Hyo KI, Jong Lae LIM